Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by Snake214on Mar 30, 2019 10:56am
65 Views
Post# 29558229

RE:Lovingstock23

RE:Lovingstock23if you look at the quarter yoy they did about $150k in product and the rest was a consulting contract they had at the time. This yesr they did $450k in product basically 3x based on primarily only selling joints for $3 bucks a piece net on only the BC website. Ontario didn't even ship until mid point of the next quarter so we will only see a bit of it in the next financials as well. 

while they are expanding it seems their biggest issue is still supply. If they don't have more product in the OCS warehouse then they are down to a handful of LAndrace Sativa joints and a 100 or so of the 7g CBD Indica.  on teh medical front it looks like they are over run with sign ups as well.

Add to that the fact that all the stuff about backroom underhanded dealings regurgitated on this board are only effective for people who have not read the financial statements whihc outline all of the arms length transactions.  





Bullboard Posts